Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetics
80%
Toxicity
77%
Irinotecan
69%
CYP3A4
68%
Drug
62%
CYP2D6
46%
Pharmacogenetics
43%
Tamoxifen
39%
Tacrolimus
35%
Fluoropyrimidine
33%
Cytochrome P450 3A5
29%
Incidence
28%
Adverse Event
26%
Malignant Neoplasm
21%
Enzyme
21%
Mycophenolate Mofetil
19%
Paclitaxel
18%
Neutropenia
18%
Midazolam
17%
Anticarcinogen
16%
Pharmacokinetic Parameter
16%
ABCG2
16%
Non Small Cell Lung Cancer
15%
Solid Malignant Neoplasm
15%
Diarrhea
15%
Febrile Neutropenia
15%
Side Effect
14%
Dihydropyrimidine Dehydrogenase
14%
Pharmacodynamics
14%
Cytochrome P450
14%
Drug Metabolizing Enzyme
14%
Active Metabolite
13%
CYP3A
12%
CYP2C19
12%
Neoplasm
12%
Acute Graft Rejection
12%
Erythromycin
11%
Fluorouracil
11%
Endoxifen
11%
Uracil
10%
Breast Cancer
10%
Therapeutic Drug Monitoring
9%
Aldosterone
9%
Renin
9%
Risperidone
9%
Morphine
9%
Hand Foot Syndrome
9%
Phosphotransferase Inhibitor
9%
Metformin
9%
Allopurinol
9%
Biochemistry, Genetics and Molecular Biology
Association
62%
Genotyping
53%
Single-Nucleotide Polymorphism
45%
Dose
44%
Pharmacogenetics
42%
Pharmacokinetics
40%
Allele
35%
CYP3A5
35%
Nested Gene
34%
CYP3A4
32%
CYP2D6
28%
Metabolic Pathway
28%
Mutation
28%
DNA
27%
Sample
27%
Lysozyme
22%
Troponin T
20%
Overall Survival
20%
Cytochrome P450
19%
Germline
19%
Age
19%
Accuracy
17%
Phenotype
16%
Blood Level
15%
Time
15%
Acetic Acid
15%
Midazolam
14%
Incidence
14%
Development
13%
Steady State
12%
Genetic Risk
10%
Progression Free Survival
10%
Tandem Mass Spectrometry
10%
Solution and Solubility
10%
Electric Potential
10%
Pharmacogenomics
10%
N-Terminus
10%
Clearance
9%
Tumor Progression
9%
DNA Mutation
9%
Survival
9%
Cardiac Troponin
9%
Birth Weight
9%
Tryptophan
9%
Kinase
9%
Small Molecule
9%
Liquid Chromatography Mass Spectrometry
9%
Pregnancy
9%
Childhood
9%
Pressure
9%
Medicine and Dentistry
Patient
100%
Therapeutic Procedure
43%
Genotype
38%
Tacrolimus
26%
Toxicity
22%
Chemotherapeutic Agent
21%
Drug
21%
Transplantation
21%
Association
20%
Cells
20%
Pharmacogenetics
20%
Blood
19%
Prostate Cancer
18%
Serum
16%
Non Small Cell Lung Cancer
16%
Combination Therapy
16%
Inpatient
14%
Man
13%
Health Care Cost
13%
Plasma
12%
Drug Therapy
11%
Gene Frequency
11%
Neoplasm
11%
Single Nucleotide Polymorphism
11%
Fluoropyrimidine
11%
CYP2D6
11%
Clopidogrel
11%
Kidney Graft
11%
Genetic Risk
10%
Progression Free Survival
10%
Analysis
10%
Diabetes Mellitus
10%
Measurement
9%
Gene
9%
Mutant
9%
Reagent
9%
Programmed Death-Ligand 1
9%
Bone
9%
Birth Weight
9%
Hand Foot Syndrome
9%
Clinical Guideline
9%
Troponin T
8%
Mycophenolate Mofetil
8%
Serotonin
8%
Febrile Neutropenia
8%
CYP2C19
8%
Protein Intake
8%
Capecitabine
8%
Nivolumab
8%
Cytochrome P450 3A5
8%
